All patients with multiple myeloma have had MGUS, so what is it? To learn about how multiple myeloma can develop, it’s important to first learn about a plasma cell disorder called monoclonal ...

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma. Multiple ...

Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that often precedes multiple myeloma, according to new research.

Share on Pinterest Researchers continue to study the risk factors for the blood cancer multiple myeloma. Abraham Gonzalez Fernandez/Getty Images Smoking, poor sleep, and obesity may increase the risk ...

Speakers on precursor disease addressed distinctions between MGUS and smoldering multiple myeloma, risk stratification, and new thinking on the role of immunological aging, especially how it affects ...

Contrary to earlier studies, the not-entirely-rare condition known as monoclonal gammopathy of undetermined significance (MGUS) did not appear to raise risk for autoimmune disease when examined in the ...

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...

Five years ago, investigators in Iceland sought to evaluate what would happen if screening for MGUS were widely available—and whether it would improve overall survival. Before the blood cancer ...

Monoclonal gammopathy is characterized by an abnormal monoclonal (M)-protein in the blood. This protein is associated with renal toxicity related to the underlying gammopathy. "The key finding of our ...